Status:
COMPLETED
Effect of Emdogain® on Soft Tissue Wound Healing
Lead Sponsor:
Amir Azarpazhooh
Collaborating Sponsors:
Institut Straumann AG
Conditions:
Periodontal Inflammation
Crown Lengthening
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized, controlled, single-center study is to compare the effects of Emdogain®, a regenerative biomaterial, on post-operative pain, wound healing and inflammation of treated sites...
Detailed Description
This randomized, controlled, single-center study intends to investigate the effects of Emdogain® on wound healing, postoperative pain and inflammation of treated sites after crown lengthening procedur...
Eligibility Criteria
Inclusion
- Patients who:
- Were capable and willing to provide consent and complete treatment as well as follow-up appointments
- Were over the age of 18 years old
- Required surgical crown lengthening for functional reasons as outlined in background
- Had no contraindications to surgery (these include periodontal contraindications to crown lengthening such as poor crown-to-root ratio, furcation exposure or esthetic concerns)
Exclusion
- Patients who were unable to provide informed consent
- Pregnant women
- Women receiving estrogen therapy
- Patients who had received systemic antibiotics within the past 6 months
- Patients with severe systemic disease (ASA 3+) including: poorly controlled diabetes, blood dyscrasias, liver disease, immunosuppressive disorders, malignancy or who have had previous radiotherapy
- Patients with untreated, active periodontal disease
Key Trial Info
Start Date :
April 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06179277
Start Date
April 8 2019
End Date
October 11 2021
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Toronto, Faculty of Dentistry
Toronto, Ontario, Canada, M5G 1G6